GW Pharmaceuticals Working Capital

GWPH -- USA Stock  

USD 100.60  5.31  5.01%

GW Pharmaceuticals working-capital fundamental analysis lookup allows you to check this and other indicators for GW Pharmaceuticals Plc or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

GW Pharmaceuticals Working Capital Analysis

Working Capital is measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is important indicator of the firm ability to continue its normal operations without additional debt obligations. .
 2009 2016 2018 2019 (projected)
Revenues USD 12,737,000  12,730,000  14,639,500  14,284,930 
Revenues 12,737,000  12,730,000  14,639,500  131,580,000 
Working Capital 
Current Assets 
Current Liabilities 
More About Working Capital | All Equity Analysis
GW Pharmaceuticals Working Capital  =
369.57 M
GW Pharmaceuticals ValuationFundamentalsBuy or Sell

GW Pharmaceuticals Working Capital Over Time Pattern

 GW Pharmaceuticals Working Capital 

About Working Capital

Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Compare to competition

GW Pharmaceuticals Working Capital Assessment

Capital Expenditure
GW Pharmaceuticals Plc has Working Capital of 369.57 M. This is 13.18% lower than that of the Healthcare sector, and significantly higher than that of Drug Manufacturers?General industry, The Working Capital for all stocks is 75.0% higher than the company.

Did you try this?

Run Transaction History Now


Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module

GW Pharmaceuticals current financial ratios